Edema formation in acute
inflammation can be induced through lowering of interstitial fluid pressure (Pif) and seems to involve dynamic beta 1
integrin-mediated interactions between dermal cells and extracellular matrix fibers. The present experiments investigate the role of beta 1
integrins in the control of Pif. The anti-inflammatory
drug alpha-trinositol (1,2,6-D-myo-inositol trisphosphate) stabilizes Pif in acute
inflammation. Pretreatment with 5 mg IV
alpha-trinositol in
pentobarbital-anesthetized rats inhibited the lowering in Pif and the
edema formation induced by subdermal injection of anti-beta 1
integrin IgG. This stabilization of the beta 1
integrin function in vivo was paralleled by effects of
alpha-trinositol on contraction of fibroblast-populated three-dimensional
collagen lattices in vitro.
alpha-Trinositol was additive to the known stimulatory effect of
platelet-derived growth factor-BB on the final gel size in the
collagen gel contraction assay. Furthermore,
alpha-trinositol counteracted the inhibitory effect of anti-beta 1
integrin Fab fragments on
collagen gel contraction. Finally, subdermal injection of dibutyryl-cAMP (db-cAMP) induced increased negativity of Pif to the same extent as did anti-beta 1
integrin antibodies, and in vitro db-cAMP reduced the ability of fibroblasts to contract
collagen gels. The latter effect was opposed by
alpha-trinositol. The data demonstrate that
alpha-trinositol modulates beta 1
integrin function and may do so via intracellular pathways in turn affecting the function and/or cell surface expression of beta 1
integrins and suggest that
alpha-trinositol can serve as a tool to study
integrin function. Furthermore, the data indicate that the
collagen contraction assays may provide important information of the control of Pif in vivo.